Skip to main content
. 2019 Dec 5;29(12):478–486. doi: 10.2188/jea.JE20180098

Table 4. Results of multivariable analysis in the relationship between quartile concentration of metals and allergen-specific IgEs.

Quartile
concentration of
metals (ng/g)
HDM-specific IgE, UA/mL JCP-specific IgE, UA/mL Animal dander-specific IgE, UA/mL



Low
(<0.35;
n = 7,606)
High
(≥0.35;
n = 6,802)
OR (95% CI)a P valuea Low
(<0.35;
n = 6,453)
High
(≥0.35;
n = 7,955)
OR (95% CI)a P valuea Low
(<0.35;
n = 11,438)
High
(≥0.35;
n = 2,970)
OR (95% CI)a P valuea
Cd                        
Q1 (≤0.495) 1,841 1,754 1.00 (referent)   1,586 2,009 1.00 (referent)   2,797 798 1.00 (referent)  
Q2 (0.496–0.657) 1,924 1,674 0.92 (0.84–1.02) 0.100 1,628 1,970 0.94 (0.85–1.04) 0.228 2,831 767 0.98 (0.87–1.10) 0.746
Q3 (0.658–0.897) 1,943 1,661 0.94 (0.85–1.04) 0.225 1,570 2,034 1.04 (0.94–1.15) 0.464 2,905 699 0.90 (0.80–1.02) 0.097
Q4 (≥0.898) 1,898 1,713 1.04 (0.94–1.15) 0.498 1,669 1,942 0.98 (0.89–1.09) 0.747 2,905 706 0.94 (0.83–1.07) 0.368
Pb                        
Q1 (≤4.78) 1,866 1,734 1.00 (referent)   1,623 1,977 1.00 (referent)   2,860 740 1.00 (referent)  
Q2 (4.79–5.92) 1,855 1,736 1.00 (0.90–1.10) 0.935 1,618 1,973 1.00 (0.91–1.11) 0.953 2,850 741 0.99 (0.87–1.11) 0.815
Q3 (5.93–7.42) 1,937 1,670 0.92 (0.84–1.02) 0.103 1,591 2,016 1.06 (0.96–1.17) 0.252 2,858 749 1.01 (0.90–1.14) 0.870
Q4 (≥7.43) 1,948 1,662 0.91 (0.83–1.01) 0.073 1,621 1,989 1.04 (0.94–1.15) 0.407 2,870 740 0.99 (0.88–1.12) 0.885
Hg                        
Q1 (≤2.55) 1,858 1,726 1.00 (referent)   1,754 1,830 1.00 (referent)   2,801 783 1.00 (referent)  
Q2 (2.56–3.61) 1,926 1,680 0.91 (0.82–1.00) 0.057 1,684 1,922 1.06 (0.96–1.18) 0.214 2,845 761 0.93 (0.83–1.05) 0.238
Q3 (3.62–5.11) 1,856 1,727 0.98 (0.89–1.08) 0.734 1,543 2,040 1.23 (1.12–1.36) <0.001 2,865 718 0.88 (0.78–0.99) 0.031
Q4 (≥5.12) 1,966 1,669 0.86 (0.78–0.95) 0.003 1,472 2,163 1.35 (1.22–1.49) <0.001 2,927 708 0.81 (0.72–0.92) 0.001
Se                        
Q1 (≤156) 1,755 1,659 1.00 (referent)   1,624 1,790 1.00 (referent)   2,680 734 1.00 (referent)  
Q2 (157–168) 1,878 1,719 1.00 (0.90–1.10) 0.951 1,617 1,980 1.15 (1.04–1.27) 0.008 2,813 784 1.06 (0.94–1.19) 0.355
Q3 (169–181) 1,948 1,663 0.91 (0.82–1.01) 0.063 1,593 2,018 1.17 (1.06–1.30) 0.002 2,912 699 0.88 (0.78–1.00) 0.046
Q4 (≥182) 2,025 1,761 0.94 (0.85–1.04) 0.233 1,619 2,167 1.26 (1.14–1.39) <0.001 3,033 753 0.95 (0.84–1.07) 0.414
Mn                        
Q1 (≤12.4) 1,856 1,628 1.00 (referent)   1,550 1,934 1.00 (referent)   2,711 773 1.00 (referent)  
Q2 (12.5–15.1) 1,924 1,704 1.01 (0.92–1.12) 0.793 1,666 1,962 0.97 (0.87–1.07) 0.494 2,900 728 0.87 (0.77–0.98) 0.024
Q3 (15.2–18.4) 1,907 1,754 1.03 (0.94–1.14) 0.519 1,614 2,047 1.03 (0.93–1.14) 0.594 2,941 720 0.83 (0.74–0.94) 0.002
Q4 (≥18.5) 1,919 1,716 1.01 (0.92–1.12) 0.794 1,623 2,012 1.02 (0.92–1.13) 0.681 2,886 749 0.90 (0.79–1.01) 0.070

IgE, immunoglobulin E.

aOdds ratios and corresponding 95% confidence intervals and P values were obtained using multivariable logistic regression analysis adjusted for age, BMI, allergic diseases (asthma, allergic rhinitis, atopic dermatitis, allergic conjunctivitis, food allergy, drug allergy), smoking during pregnancy, smoking habits of partner, alcohol consumption during pregnancy, owning pets, month of T1 blood sampling, and geographic region.